Katherine E. Burgomaster

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 298 citations · Full text

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

Kate Luisi, Kaitlyn M. Morabito, Katherine E. Burgomaster et al. · Science Advances · 2020 · 79 citations · Full text

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

Brooke Bollman, Naveen Nunna, Kapil Bahl et al. · npj Vaccines · 2023 · 56 citations · Full text

Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice

Brett W. Jagger, Kimberly A. Dowd, Rita E. Chen et al. · The Journal of Infectious Diseases · 2019 · 52 citations · Full text

DNA vaccination before conception protects Zika virus–exposed pregnant macaques against prolonged viremia and improves fetal outcomes

Koen K. A. Van Rompay, Rebekah I. Keesler, Amir Ardeshir et al. · Science Translational Medicine · 2019 · 48 citations · Full text